222 related articles for article (PubMed ID: 20923321)
1. Film coated tablets (ColoPulse technology) for targeted delivery in the lower intestinal tract: influence of the core composition on release characteristics.
Schellekens RC; Baltink JH; Woesthuis EM; Stellaard F; Kosterink JG; Woerdenbag HJ; Frijlink HW
Pharm Dev Technol; 2012; 17(1):40-7. PubMed ID: 20923321
[TBL] [Abstract][Full Text] [Related]
2. Design, development and in vitro-in vivo study of a colon-specific fast disintegrating tablet.
Kshirsagar SJ; Bhalekar MR; Umap RR
Pharm Dev Technol; 2011 Oct; 16(5):449-56. PubMed ID: 20486875
[TBL] [Abstract][Full Text] [Related]
3. Development and in vitro evaluation of mesalamine delayed release pellets and tableted reservoir-type pellets.
Bendas ER; Christensen JM; Ayres JW
Drug Dev Ind Pharm; 2010 Apr; 36(4):393-404. PubMed ID: 19740039
[TBL] [Abstract][Full Text] [Related]
4. Eudragit-S, Eudragit-L and cellulose acetate phthalate coated polysaccharide tablets for colonic targeted delivery of azathioprine.
Kotagale N; Maniyar M; Somvanshi S; Umekar M; Patel CJ
Pharm Dev Technol; 2010; 15(4):431-7. PubMed ID: 20236031
[TBL] [Abstract][Full Text] [Related]
5. Modified release from hydroxypropyl methylcellulose compression-coated tablets.
Rujivipat S; Bodmeier R
Int J Pharm; 2010 Dec; 402(1-2):72-7. PubMed ID: 20883759
[TBL] [Abstract][Full Text] [Related]
6. Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex.
Piao ZZ; Lee MK; Lee BJ
Int J Pharm; 2008 Feb; 350(1-2):205-11. PubMed ID: 17928177
[TBL] [Abstract][Full Text] [Related]
7. Novel mesalamine-loaded beads in tablets for delayed release of drug to the colon.
Nguyen C; Christensen JM; Ayres JW
Pharm Dev Technol; 2012; 17(1):73-83. PubMed ID: 20923254
[TBL] [Abstract][Full Text] [Related]
8. Citric acid as a pH-regulating additive in granules and the tablet matrix in enteric-coated formulations for colon-specific drug delivery.
Nykänen P; Sten T; Jürjenson H; Veski P; Marvola M
Pharmazie; 2004 Apr; 59(4):268-73. PubMed ID: 15125570
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers.
Kadam VD; Gattani SG
Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544
[TBL] [Abstract][Full Text] [Related]
10. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
Varum FJ; Hatton GB; Freire AC; Basit AW
Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
[TBL] [Abstract][Full Text] [Related]
11. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
[TBL] [Abstract][Full Text] [Related]
12. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends.
Rujivipat S; Bodmeier R
Eur J Pharm Biopharm; 2010 Nov; 76(3):486-92. PubMed ID: 20868750
[TBL] [Abstract][Full Text] [Related]
13. Tailoring of drug delivery of 5-fluorouracil to the colon via a mixed film coated unit system.
Kumar RV; Sinha VR
Acta Pharm; 2011 Sep; 61(3):343-51. PubMed ID: 21945913
[TBL] [Abstract][Full Text] [Related]
14. Effect of core size and excipients on the lag time and drug release from a pulsatile drug delivery system.
Efentakis M; Iliopoyloy A; Siamidi A
Drug Dev Ind Pharm; 2011 Jan; 37(1):113-20. PubMed ID: 20615155
[TBL] [Abstract][Full Text] [Related]
15. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
16. A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.
Ibekwe VC; Fadda HM; Parsons GE; Basit AW
Int J Pharm; 2006 Feb; 308(1-2):52-60. PubMed ID: 16356670
[TBL] [Abstract][Full Text] [Related]
17. In-vitro characterization of 5-aminosalicylic acid release from MMX mesalamine tablets and determination of tablet coating thickness.
Tenjarla S; Abinusawa A
Adv Ther; 2011 Jan; 28(1):62-72. PubMed ID: 21088944
[TBL] [Abstract][Full Text] [Related]
18. Design, development and optimization of a novel time and pH-dependent colon targeted drug delivery system.
Patel MM; Shah TJ; Amin AF; Shah NN
Pharm Dev Technol; 2009; 14(1):62-9. PubMed ID: 18802844
[TBL] [Abstract][Full Text] [Related]
19. Exploiting gastrointestinal bacteria to target drugs to the colon: an in vitro study using amylose coated tablets.
Wilson PJ; Basit AW
Int J Pharm; 2005 Aug; 300(1-2):89-94. PubMed ID: 16023805
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of a time-specific pulsatile-release tablet of aceclofenac: a solution for morning pain in rheumatoid arthritis.
Qureshi J; Ahuja A; Baboota S; Chutani K; Jain S; Ali J
Methods Find Exp Clin Pharmacol; 2009; 31(1):15-23. PubMed ID: 19357794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
